Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Tradeweb typically reports before market open, meaning Day 0 captures the first full trading session reaction to results, while Day +1 reflects follow-through momentum.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-07-30 | -$10.38 (-9.60%) | $7.69 (7.11%) | +$2.70 (+2.76%) | $5.43 (5.56%) |
| 2026-04-29 | +$5.76 (+5.13%) | $11.21 (9.98%) | -$4.87 (-4.12%) | $4.43 (3.75%) |
| 2026-02-05 | +$8.71 (+8.64%) | $11.20 (11.11%) | +$2.60 (+2.37%) | $4.17 (3.81%) |
| 2025-10-30 | -$1.29 (-1.22%) | $4.96 (4.70%) | +$1.24 (+1.19%) | $2.82 (2.71%) |
| 2025-07-30 | +$7.81 (+5.65%) | $9.88 (7.14%) | -$7.57 (-5.18%) | $6.03 (4.13%) |
| 2025-04-30 | +$0.92 (+0.67%) | $7.64 (5.56%) | -$0.23 (-0.17%) | $3.52 (2.54%) |
| 2025-02-06 | -$1.76 (-1.41%) | $5.25 (4.19%) | +$0.93 (+0.75%) | $2.50 (2.02%) |
| 2024-10-30 | -$2.66 (-2.02%) | $4.19 (3.19%) | -$1.79 (-1.39%) | $2.57 (2.00%) |
| Avg Abs Move | 4.29% | 6.62% | 2.24% | 3.31% |
Historical price behavior shows moderate volatility around earnings, with an average absolute Day 0 move of 4.29% and Day +1 follow-through averaging 2.24%. The most recent Q2 2026 report triggered a sharp -9.60% decline on Day 0, the largest move in the dataset, though it was followed by a +2.76% recovery on Day +1—suggesting initial selling pressure gave way to bargain hunting. Prior to that, Q1 2026 saw a +5.13% Day 0 gain with a -4.12% Day +1 reversal, indicating profit-taking after the initial pop.
Looking further back, Q4 2025 delivered a strong +8.64% Day 0 rally with +2.37% Day +1 continuation, while Q3 2025 was relatively muted at -1.22% Day 0 and +1.19% Day +1. The pattern reveals directional unpredictability—moves have been split between gains and losses—but the magnitude has been meaningful, with Day 0 ranges averaging 6.62%. Investors should prepare for a mid-single-digit percentage swing on earnings day, with the direction likely hinging on guidance commentary around the Trumid integration and volume trends.
| Metric | Value |
|---|---|
| Expiration Date | 11/20/26 (DTE 23) |
| Expected Move | $4.25 (3.55%) |
| Expected Range | $115.57 to $124.07 |
| Implied Volatility | 33.15% |
The options market is pricing a 3.55% expected move for the November 20 expiration, which is moderately below the 4.29% average absolute Day 0 move observed historically. This suggests options traders are anticipating a somewhat calmer reaction than the historical average, though still meaningful volatility. The implied range of $115.57 to $124.07 brackets the current price, with the market assigning roughly equal probability to upside and downside outcomes.
Analysts maintain a bullish stance on Tradeweb, with the consensus rating at 3.94 out of 5.0 (between Hold and Buy, leaning toward Buy). The average price target of $127.73 implies 6.6% upside from the current price of $119.82. Among the 17 analysts covering the stock, 7 rate it a Strong Buy, 2 assign Moderate Buy ratings, and 8 have Hold ratings—with no Sell or Strong Sell recommendations. This distribution reflects broad confidence in the company's growth trajectory, though the significant Hold contingent suggests some caution around valuation.
Sentiment has improved over the past month, with the consensus rating rising from 3.88 to 3.94 and the number of Strong Buy ratings increasing from 6 to 7. This positive shift coincides with upward estimate revisions and recent price target increases from major firms. The target range spans from a low of $102.00 to a high of $182.00, with the wide spread reflecting differing views on how much credit to give the company's market position and growth potential versus near-term integration risks.
The improved sentiment trend suggests analysts are gaining confidence in Tradeweb's ability to execute on both organic growth and the Trumid acquisition. However, the $127.73 mean target implies relatively modest upside, indicating the market has already priced in much of the positive narrative. Investors should watch whether Q3 results and management commentary can justify the premium valuation and support further target increases.
Tradeweb enters earnings with strengthening technical momentum, as the Barchart Technical Opinion has shifted from a 72% Sell signal one month ago to a 40% Buy signal last week and now stands at a 72% Buy signal currently. This dramatic reversal reflects improving price action as the stock has rallied above key moving averages.
Timeframe Analysis:
Trend Characteristics: The technical environment shows Good strength with Average direction, suggesting solid momentum but not an overextended or parabolic move—a balanced setup for absorbing earnings volatility.
The stock is currently trading at $119.82, positioned above the 10-day ($118.70), 20-day ($113.33), 50-day ($107.72), 100-day ($104.15), and 200-day ($109.01) moving averages but below the 5-day ($121.48). This configuration indicates a strong uptrend across all major timeframes, with the stock having pulled back slightly from very recent highs. The progression of moving averages—with shorter-term averages above longer-term ones—confirms positive momentum.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $121.48 | 50-Day MA | $107.72 |
| 10-Day MA | $118.70 | 100-Day MA | $104.15 |
| 20-Day MA | $113.33 | 200-Day MA | $109.01 |
Key resistance likely sits near the 5-day moving average at $121.48, which the stock recently tested, while support appears layered at the 10-day ($118.70) and 20-day ($113.33) levels. The technical setup is supportive heading into earnings, with the stock in a clear uptrend and trading well above all major moving averages. However, the slight pullback from the 5-day MA suggests some profit-taking or consolidation ahead of the report. The 100% Short-term Buy signal indicates strong near-term momentum, but investors should be prepared for volatility given the historical 4-6% average earnings-day range. A beat-and-raise scenario could propel the stock toward the $127.73 analyst price target, while any disappointment on Trumid integration commentary or volume trends could test support at the 10-day or 20-day moving averages.